SARS-CoV-2 Mpro-IN-17 (compound S5-28) is an orally active, non-covalent inhibitor of SARS-CoV-2 Mpro, with an EC50 value of 1.35 µM. It is applicable for research related to COVID-19.
Formula:
C20H19BrClN3O2
Target:
SARS-CoV
* VAT and and shipping costs not included. Errors and price changes excepted